Drug of Choice

The Wall Street Journal reports that GlaxoSmithKline is seeking direction from healthcare officials in France, Italy, Spain, and the UK on what drugs under development at Glaxo should be pursued. The pharma company hopes that this will give rise to more drugs that the healthcare systems will buy.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.